Cargando…
Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine
The extent of removal of the uremic toxins in hemodialysis (HD) therapies depends primarily on the dialysis membrane characteristics and the solute transport mechanisms involved. While designation of ‘flux’ of membranes as well toxicity of compounds that need to be targeted for removal remain unreso...
Autores principales: | Canaud, Bernard, Stuard, Stefano, Laukhuf, Frank, Yan, Grace, Canabal, Maria Ines Gomez, Lim, Paik Seong, Kraus, Michael A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711767/ https://www.ncbi.nlm.nih.gov/pubmed/34987785 http://dx.doi.org/10.1093/ckj/sfab198 |
Ejemplares similares
-
From electronic health records to clinical management systems: how the digital transformation can support healthcare services
por: Barbieri, Carlo, et al.
Publicado: (2023) -
Multitargeted interventions to reduce dialysis-induced systemic stress
por: Canaud, Bernard, et al.
Publicado: (2021) -
War in Ukraine and dialysis treatment: human suffering and organizational challenges
por: Novakivskyy, Volodymyr, et al.
Publicado: (2023) -
Expanded hemodialysis: what’s up, Doc?
por: García-Prieto, Ana, et al.
Publicado: (2023) -
Intradialytic parenteral nutrition for patients on hemodialysis: when, how and to whom?
por: Carrero, Juan J, et al.
Publicado: (2022)